Digestive Endoscopy Is Not a Major Risk Factor for Transmitting Hepatitis C Virus

Alessia Ciancio,Paola Manzini,Franco Castagno,Sergio D'Antico,Paolo Reynaudo,Laura Coucourde,Giovannino Ciccone,Mario Del Piano,Marco Ballarè,Sergio Peyre,Roberto Rizzi,Claudio Barletti,Mauro Bruno,Stefania Caronna,Patrizia Carucci,Wilma De Bernardi Venon,Claudio De Angelis,Anna Morgando,Alessandro Musso,Alessandro Repici,Mario Rizzetto,Giorgio Saracco
DOI: https://doi.org/10.7326/0003-4819-142-11-200506070-00008
IF: 39.2
2005-06-07
Annals of Internal Medicine
Abstract:BACKGROUND: The potential role of digestive endoscopy as a mode for transmission of hepatitis C virus (HCV) is controversial.OBJECTIVE: To evaluate the role of digestive endoscopy in transmitting HCV by comparing the incidence of HCV infection in a cohort of patients undergoing endoscopy and in a cohort of blood donors.DESIGN: Prospective cohort study.SETTING: 3 endoscopic units and 2 blood banks in northwestern Italy.PATIENTS: The potentially exposed cohort consisted of 9188 outpatients consecutively recruited from 3 endoscopic units. Of 9008 patients negative for antibody to HCV (anti-HCV), 8260 (92%) were retested for anti-HCV 6 months after endoscopy. The unexposed cohort consisted of 51,230 healthy, anti-HCV-negative persons who donated blood at 2 blood banks in the same area and during the same time period; 38,280 of them (75%) were tested again for anti-HCV 6 to 48 months after the first blood donation (95,317 person-years of observation).MEASUREMENTS: Differences in the anti-HCV seroconversion rate between the exposed cohort (patients undergoing endoscopy) and the unexposed cohort (blood donors). Seroconversion was evaluated by a third-generation enzyme immunoassay for anti-HCV; persons positive for anti-HCV were tested for HCV RNA by polymerase chain reaction.RESULTS: All 8260 persons undergoing endoscopy remained negative for anti-HCV 6 months after the procedure (risk per 1000 persons, 0 [95% CI, 0 to 0.465]); in particular, none of the 912 patients who underwent endoscopy with the same instrument previously used on HCV carriers showed anti-HCV seroconversion (risk per 1000 persons, 0 [CI, 0 to 4.195]). Four blood donors became positive for anti-HCV and HCV RNA (mean follow-up, 2.49 years; 0.042 case per 1000 person-years [CI, 0.011 to 0.107 case per 1000 person-years]); each had undergone minor surgery before the second test.LIMITATIONS: In the endoscopy cohort, 8.3% of patients were lost to follow-up.CONCLUSIONS: These findings support the hypothesis that properly performed digestive endoscopy is not a major risk factor for the transmission of HCV.
medicine, general & internal
What problem does this paper attempt to address?